Items where authors include "Biller, B.M.K."

Article

Fleseriu, M., Newell-Price, J., Pivonello, R. et al. (12 more authors) (2022) Long-term outcomes of osilodrostat in Cushing’s disease: LINC 3 study extension. European Journal of Endocrinology, 187 (4). pp. 531-541. ISSN 0804-4643

Pivonello, R., Fleseriu, M., Newell-Price, J. et al. (14 more authors) (2020) Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3) : a multicentre phase III study with a doubleblind, randomised withdrawal phase. The Lancet Diabetes & Endocrinology, 8 (9). pp. 748-761. ISSN 2213-8587

Newell-Price, J., Pivonello, R., Tabarin, A. et al. (9 more authors) (2020) Use of late-night salivary cortisol to monitor response to medical treatment in Cushing’s disease. European Journal of Endocrinology, 182 (2). pp. 207-217. ISSN 0804-4643

Fleseriu, M., Petersenn, S., Biller, B.M.K. et al. (9 more authors) (2019) Long‐term efficacy and safety of once‐monthly pasireotide in Cushing's disease: A Phase III extension study. Clinical Endocrinology, 91 (6). pp. 776-785. ISSN 0300-0664

Johannsson, G., Bidlingmaier, M., Biller, B.M.K. et al. (28 more authors) (2018) Growth Hormone Research Society perspective on biomarkers of GH action in children and adults. Endocrine Connections, 7 (3). R126-R134. ISSN 2049-3614

Lacroix, A., Gu, F., Gallardo, W. et al. (12 more authors) (2018) Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial. The Lancet Diabetes and Endocrinology, 6 (1). pp. 17-26. ISSN 2213-8587

Findling, J.W., Fleseriu, M., Newell-Price, J. et al. (5 more authors) (2016) Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing’s disease: 12-month, Phase III pasireotide study. Endocrine, 54 (2). pp. 516-523. ISSN 1355-008X

Allen, D.B., Backeljauw, P., Bidlingmaier, M. et al. (37 more authors) (2016) GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 174 (2). P1-P9. ISSN 0804-4643